ADCT ADC Therapeutics SA

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Mar 17, 2026 Processed 2mo ago SEC 9999999995-26-000834
IPO/offering going effective
Final — all horizons settled through T+60d
ADCT ▼ -73.24% at T+60d
NEUTRAL call ✗ call lost -73.24% · α vs SPY -83.10% · entry $4.11 → $1.10
Currently $1.05 · -74.45% from $4.11 entry
Entry anchored
Mar 16, 03:59 PM ET
via Databento tick
T+1d
-2.43%
call -2.43% · α -1.03%
$4.01
settled 3mo ago
T+5d
-4.14%
call -4.14% · α -1.48%
$3.94
settled 3mo ago
T+20d
+6.33%
call +6.33% · α +2.03%
$4.37
settled 8w ago
T+60d
-73.24%
call -73.24% · α -83.10%
$1.10
settled yesterday

Price Chart

Loading chart...

Executive Summary

ADC Therapeutics SA has announced the effectiveness of a shelf registration (Form S-3) filed with the SEC, allowing the company to issue unspecified amounts of securities from time to time. The filing became effective on March 16, 2026, enabling future capital raises under flexible terms.

Actionable Insight

Traders should monitor for future announcements of actual offerings under this shelf registration, which could lead to equity dilution or debt issuance. The lack of immediate capital raise limits near-term impact, but the overhang of potential dilution may weigh on sentiment if market conditions deteriorate.

Key Facts

  • Shelf registration on Form S-3 has become effective as of March 16, 2026.
  • The company may now offer and sell unspecified amounts of securities in one or more offerings.
  • No specific offering size, pricing, or securities type is disclosed in the filing.
  • This is a routine capital markets update, not an IPO or immediate follow-on offering.

Financial Impact

Not specified

dilutioncashdebt

Risk Factors

  • Potential for future equity dilution if common stock is issued under the shelf.
  • Market perception of negative timing if an offering is launched during weak performance.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000834
Document: 9999999995-26-000834-index.html9999999995-26-000834
Document: 9999999995-26-000834.txt9999999995-26-000834
5 reports for ADCT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ADCT — sortable, filterable
Type Now
Jun 3, 2026
9d ago
8-K
MIXED ★ 6/10
$1.32 $1.03▼ −21.97%▼ −19.40%$1.05 (−20.45%)
May 4, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$3.68 $3.76▲ +2.17%▲ +1.38%$1.05 (−71.47%)
Apr 20, 2026
7w ago
DEFA14A
NEUTRAL ★ 2/10
$4.25 $4.11▼ −3.29%▼ −2.64%$1.05 (−75.29%)
Mar 17, 2026
12w ago
EFFECT
NEUTRAL ★ 4/10
$4.11 $4.01▼ −2.43%▼ −1.03%$1.05 (−74.45%)
Mar 10, 2026
13w ago
S-3
BEARISH ★ 6/10
$4.88 $4.35▲ +10.86%▲ +9.38%$1.05 (+78.48%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (49h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access